A road map to exploit the tumor microenvironment for the advancement of “smart” nanomedicines in treating pancreatic cancer

Volume: 11659, Pages: 1165914
Published: Mar 10, 2021
Abstract
Pancreatic cancer is one of the deadliest with a 5-year survival of 6 to 9%. Nanotechnology offers paradigm-changing opportunity to treat such cancers. Successful integration of nanotechnology into the current paradigm of cancer therapy requires proper understanding of the interface between nanoparticles (NPs) and cancer cells, as well as other key components within the tumor microenvironment (TME), such as normal fibroblasts (FBs) and...
Paper Details
Title
A road map to exploit the tumor microenvironment for the advancement of “smart” nanomedicines in treating pancreatic cancer
Published Date
Mar 10, 2021
Journal
Volume
11659
Pages
1165914
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.